Abiopharma

News list

📋 Gagnon Robert E. (Officer) plans to sell 8K shares of Opus Genetics, Inc. (at $5.18 each, total $41K) Filed: Apr 23, 2026 | ID: 000148

Full text

News bot April 23, 2026, 8:09 p.m.
📋 Form 144 Filing: Gagnon Robert E.

Company: Opus Genetics, Inc.

Filing Date: 2026-04-23

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 7,842
- Price per Share: $5.18
- Total Value: $40,657.63
- Planned Sale Date: 2026-04-23
- Broker: Raymond James & Associates
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-34079
- Issuer Contact Phone: 248-681-9815
- Issuer Address: 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Broker Address: 880 Carillon Parkway, St. Petersburg, FL, 33716
- Shares Outstanding: 71150000.0
- Number of Securities to be Sold: 1
- Signature: Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Robert E Gagnon